Description
This vial combines BPC-157 (2 mg) and TB-500 (2 mg) as a lower-strength pre-mixed research blend — a smaller dose format than the 10 mg/10 mg combination vial elsewhere in this catalogue, intended for labs running lower-concentration or micro-dosing comparison protocols.
The rationale for combining the two peptides in research is the same across both strengths: BPC-157’s proposed angiogenesis and growth-factor signalling alongside TB-500’s actin-binding, cell-migration mechanism, studied together to assess whether the two distinct repair pathways interact additively in tissue models.
After you place your order, a licensed physician will speak with you directly on a live call to review your health history and confirm a prescription is medically appropriate before anything ships. If your order isn’t approved, our team will contact you directly instead of shipping it. Reconstitute with bacteriostatic water immediately before use and store refrigerated, protected from light.
